AcuraStem, a patient-based biotechnology company developing disease-modifying therapies for amyotrophic lateral sclerosis (ALS), today announced it has received a two-year research grant from Target ...
There are two channels of enhanced AD timers for independent driving of dual FOC. Hardware phase-shifted ADC trigger linkage, ...
New study reveals distinct gene regulatory networks that enable hyaline cartilage formation without hypertrophy Mesenchymal ...
A 2026 consumer research report examining Whispeara's 'brain mute button' tinnitus marketing claims, ingredient research context, neural signaling theory, GABA bioavailability considerations, and veri ...
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, United States College of Health Solutions, Arizona State University, Phoenix, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results